You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Shire Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SHIRE, and what generic and branded alternatives to SHIRE drugs are available?

SHIRE has twenty-four approved drugs.

Summary for Shire

US Patents:	0
Tradenames:	17
Ingredients:	15
NDAs:	24
Patent Litigation for Shire:	See patent lawsuits for Shire
PTAB Cases with Shire as patent owner:	See PTAB cases with Shire as patent owner

Drugs and US Patents for Shire

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	DOPAR	levodopa	TABLET;ORAL	016913-004	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Shire	FURACIN	nitrofurazone	CREAM;TOPICAL	083789-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Shire	SALUTENSIN-DEMI	hydroflumethiazide; reserpine	TABLET;ORAL	012359-004	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Shire	DOPAR	levodopa	CAPSULE;ORAL	016913-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Shire	PRO-BANTHINE	propantheline bromide	TABLET;ORAL	008732-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Shire	DEXTROSTAT	dextroamphetamine sulfate	TABLET;ORAL	084051-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Shire

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-002	Jun 19, 1990	3,864,487	⤷ Sign Up
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-003	Jun 19, 1990	3,740,395	⤷ Sign Up
Shire	SUPPRELIN	histrelin acetate	INJECTABLE;INJECTION	019836-001	Dec 24, 1991	4,244,946	⤷ Sign Up
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-003	Jun 19, 1990	3,864,487	⤷ Sign Up
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-001	Jun 19, 1990	3,740,395	⤷ Sign Up
Shire	ETHMOZINE	moricizine hydrochloride	TABLET;ORAL	019753-002	Jun 19, 1990	3,740,395	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.